ZARONTIN 250 mg/5 ml, syrup bottle, 200 ml
Active ingredients: Ethosuximide
Commercialized according to BDPMDispensing in France: Prescription only
Syrupbottle, 200 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ZARONTIN 250 mg/5 ml, sirop
- Pharmaceutical form
- sirop
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre brun de 200 ml (avec ou sans bouchon sécurité enfant) avec gobelet(s) doseur(s) polypropylène
- Marketing authorisation holder
- ESSENTIAL PHARMA (M) (MALTE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Oct 1982
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68481191CIP73250795CIP133400932507955Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉTHOSUXIMIDEsirop | 5 g · 100 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.